BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18765669)

  • 1. Ectodomain lysines and suramin block of P2X1 receptors.
    Sim JA; Broomhead HE; North RA
    J Biol Chem; 2008 Oct; 283(44):29841-6. PubMed ID: 18765669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X1 receptor antagonist.
    Rettinger J; Braun K; Hochmann H; Kassack MU; Ullmann H; Nickel P; Schmalzing G; Lambrecht G
    Neuropharmacology; 2005 Mar; 48(3):461-8. PubMed ID: 15721178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The suramin analog 4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis (carbonylimino)))tetra-kis-benzenesulfonic acid (NF110) potently blocks P2X3 receptors: subtype selectivity is determined by location of sulfonic acid groups.
    Hausmann R; Rettinger J; Gerevich Z; Meis S; Kassack MU; Illes P; Lambrecht G; Schmalzing G
    Mol Pharmacol; 2006 Jun; 69(6):2058-67. PubMed ID: 16551782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF449: a subnanomolar potency antagonist at recombinant rat P2X1 receptors.
    Braun K; Rettinger J; Ganso M; Kassack M; Hildebrandt C; Ullmann H; Nickel P; Schmalzing G; Lambrecht G
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Sep; 364(3):285-90. PubMed ID: 11521173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of chimeras, point mutants, and molecular modeling to map the antagonist-binding site of 4,4',4″,4‴-(carbonylbis-(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakisbenzene-1,3-disulfonic acid (NF449) at P2X1 receptors for ATP.
    Farmer LK; Schmid R; Evans RJ
    J Biol Chem; 2015 Jan; 290(3):1559-69. PubMed ID: 25425641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF449, a novel picomolar potency antagonist at human P2X1 receptors.
    Hülsmann M; Nickel P; Kassack M; Schmalzing G; Lambrecht G; Markwardt F
    Eur J Pharmacol; 2003 May; 470(1-2):1-7. PubMed ID: 12787824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfonic acid octasodium salt].
    Hechler B; Magnenat S; Zighetti ML; Kassack MU; Ullmann H; Cazenave JP; Evans R; Cattaneo M; Gachet C
    J Pharmacol Exp Ther; 2005 Jul; 314(1):232-43. PubMed ID: 15792995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of selective antagonism of the P2X1 receptor for ATP by NF449 and suramin: contribution of basic amino acids in the cysteine-rich loop.
    El-Ajouz S; Ray D; Allsopp RC; Evans RJ
    Br J Pharmacol; 2012 Jan; 165(2):390-400. PubMed ID: 21671897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of analogues of NF449 confirm NF449 as the most potent and selective known P2X1 receptor antagonist.
    Kassack MU; Braun K; Ganso M; Ullmann H; Nickel P; Böing B; Müller G; Lambrecht G
    Eur J Med Chem; 2004 Apr; 39(4):345-57. PubMed ID: 15072843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of atropine- and P2X1 receptor antagonist-resistant, neurogenic contractions of the urinary bladder.
    Kennedy C; Tasker PN; Gallacher G; Westfall TD
    J Neurosci; 2007 Jan; 27(4):845-51. PubMed ID: 17251425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting individual current components of co-expressed human P2X1 and P2X7 receptors.
    Seyffert C; Schmalzing G; Markwardt F
    Curr Top Med Chem; 2004; 4(16):1719-30. PubMed ID: 15579104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel suramin analogue NF864 selectively blocks P2X1 receptors in human platelets with potency in the low nanomolar range.
    Horner S; Menke K; Hildebrandt C; Kassack MU; Nickel P; Ullmann H; Mahaut-Smith MP; Lambrecht G
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):1-13. PubMed ID: 16158305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent effects of the purinoceptor antagonists suramin and pyridoxal-5'-phosphate-6-(2'-naphthylazo-6'-nitro-4',8'-disulfonate) (PPNDS) on alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors.
    Suzuki E; Kessler M; Montgomery K; Arai AC
    Mol Pharmacol; 2004 Dec; 66(6):1738-47. PubMed ID: 15448189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of positively charged amino acids in ATP recognition by human P2X(1) receptors.
    Ennion S; Hagan S; Evans RJ
    J Biol Chem; 2000 Sep; 275(38):29361-7. PubMed ID: 10827197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of run-down of smooth muscle P2X receptor currents recorded with the amphotericin permeabilized patch technique, physiological and pharmacological characterization of the properties of mesenteric artery P2X receptor ion channels.
    Lewis CJ; Evans RJ
    Br J Pharmacol; 2000 Dec; 131(8):1659-66. PubMed ID: 11139444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning, tissue distribution and functional characterization of the chicken P2X1 receptor.
    Soto F; Krause U; Borchardt K; Ruppelt A
    FEBS Lett; 2003 Jan; 533(1-3):54-8. PubMed ID: 12505158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cultured dorsal root ganglion neuron P2X receptors.
    Grubb BD; Evans RJ
    Eur J Neurosci; 1999 Jan; 11(1):149-54. PubMed ID: 9987019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of functional P2X(1) receptors in mouse megakaryocytes.
    Ikeda M
    Thromb Res; 2007; 119(3):343-53. PubMed ID: 16626790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purinoreceptor-mediated current in myocytes from renal resistance arteries.
    Harhun MI; Povstyan OV; Gordienko DV
    Br J Pharmacol; 2010 Jun; 160(4):987-97. PubMed ID: 20590593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The suramin analogue NF279 is a novel and potent antagonist selective for the P2X(1) receptor.
    Rettinger J; Schmalzing G; Damer S; Müller G; Nickel P; Lambrecht G
    Neuropharmacology; 2000 Aug; 39(11):2044-53. PubMed ID: 10963748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.